CATX R&D Expenses
Perspective Therapeutics Inc · R&D Expenses
CATX R&D Expenses
Latest reported$95.05Mperiod ending
CATX TTM R&D Expenses ($0.00 → $95.05M)
TTM R&D Expenses
High-resolution chart · PNG
CATX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 95,053,000 | |
| 85,683,000 | |
| 76,796,000 | |
| 56,755,000 | |
| 48,444,000 | |
| 43,722,000 | |
| 37,716,000 | |
| 30,913,000 | |
| 24,538,000 | |
| 22,456,000 | |
| 20,960,000 | |
| 15,493,000 | |
| 10,548,000 | |
| 5,974,000 | |
| 2,666,000 | |
| 2,588,000 | |
| 2,582,000 | |
| 2,254,000 | |
| 2,067,000 | |
| 1,817,000 | |
| 1,427,000 | |
| 1,281,000 | |
| 1,213,000 | |
| 1,205,000 | |
| 1,126,000 | |
| 1,145,000 | |
| 1,150,000 | |
| 1,287,000 | |
| 1,474,000 | |
| 1,705,000 | |
| 1,879,000 | |
| 1,805,000 | |
| 1,747,000 | |
| 1,491,000 | |
| 1,345,000 | |
| 1,155,000 | |
| 965,000 | |
| 791,724 | |
| 647,911 | |
| 556,146 | |
| 528,049 | |
| 541,460 | |
| 499,672 | |
| 582,064 | |
| 614,771 | |
| 656,808 | |
| 669,020 | |
| 698,423 | |
| 668,803 | |
| 651,953 | |
| 653,479 | |
| 632,625 | |
| 627,107 | |
| 653,152 | |
| 630,252 | |
| 670,737 | |
| 730,579 | |
| 820,175 | |
| 876,004 | |
| 701,955 | |
| 615,163 | |
| 432,235 | |
| 343,133 | |
| 386,599 | |
| 340,959 | |
| 359,076 | |
| 562,019 | |
| 808,997 | |
| 958,665 | |
| 1,098,255 | |
| 1,230,766 | |
| 1,320,255 | |
| 1,358,075 | |
| 1,532,501 | |
| 1,535,226 | |
| 1,355,935 | |
| 1,345,163 | |
| 1,140,607 | |
| 789,658 | |
| 670,241 | |
| 450,425 | |
| 234,595 | |
| 228,401 | |
| 131,564 | |
| 105,782 | |
| 80,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |